<DOC>
	<DOCNO>NCT01314079</DOCNO>
	<brief_summary>This open follow-up clinical trial evaluate sustain efficacy safety Adipoplus inj . 10 month ( 12 month final dose injection ) Phase II clinical trial .</brief_summary>
	<brief_title>Follow-up Study Autologous Cultured Adipose-derived Stem Cells Crohn 's Fistula</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Fistula</mesh_term>
	<criteria>patient participate ANTGASC202 clinical trial patient experience Adipoplus ANTGASC202 trial patient submit write consent able obey requirement trial pregnant breast feeding autoimmune disease Crohn 's disease infectious disease include HBV , HCV HIV willing use effective contraceptive method study . active tuberculosis moderate severe active worsen Crohn 's disease receive Infliximab ANTGASC202 trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Crohn 's fistula</keyword>
	<keyword>Autologous adipose derived stem cell</keyword>
</DOC>